期刊文献+

多囊卵巢综合征诊治新进展 被引量:71

Advance in Diagnosis and Treatment of Polycystic Ovary Syndrome
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是常见的妇科内分泌疾病,是引起育龄女性无排卵性不孕的主要原因。PCOS的临床表现及生化指标具有高度的异质性,使PCOS的诊断标准难以统一,目前国际上常用的诊断标准包括美国国立卫生研究院(NIH)标准、欧洲人类生殖及胚胎学会(ESHRE)和美国生殖医学会(HSRM)制定的鹿特丹(Rotterdam)标准及美国雄激素学会(AES)标准。近年又出现了中国PCOS诊疗专家共识及美国内分泌协会(AACE)的诊治指南。因此制定并推广符合中国人特点的PCOS诊断标准迫在眉睫。PCOS确切的发病机制尚不清楚,多认为与遗传、环境、心理因素等密切相关,需进一步研究。对于有生育需求的PCOS患者,治疗方式主要包括生活方式调整、口服避孕药、胰岛素增敏剂、促排卵治疗、辅助生殖技术以及手术治疗等,应根据患者的特点选择个体化的方案。同时应加强远期管理,预防PCOS相关的远期并发症。综述PCOS现行的诊断标准、可能的发病机制及治疗方式的研究进展。 Polycystic ovary syndrome(PCOS),a common endocrinal disorder in women of reproductive age,causes the non-ovulation infertility. It is difficult to reach the consensus on the diagnostic criteria due to the high heterogeneity of clinical presentation and biochemical criterion in PCOS patients. At present,the common international criteria include NIH criteria,Rotterdam criteria and AES criteria. The expert consensus of China and the clinical practice guideline of AACE were also published. It is urgent to develop a diagnostic criterion of PCOS based on Chinese features. The accurate pathogenesis of PCOS is still unclear,which is related to genetic,environment,psychology,and/or combined factors. Based on characteristics of patients, therapy for those women with fertility requirement should be individual,including mainly the adjustment of life style,oral contraceptives,insulin sensitizing agents,ovulation treatment,assisted reproductive technology and operation. Meanwhile,the long-term management should be emphasized to avoid the long-term complications. In this article,the advance in diagnosis,pathogenesis and treatment of PCOS was discussed.
出处 《国际生殖健康/计划生育杂志》 CAS 2015年第2期160-164,共5页 Journal of International Reproductive Health/Family Planning
基金 郑州市科技创新团队项目(113PCXTD435)
关键词 多囊卵巢综合征 诊断 治疗 Polycystic ovary syndrome Diagnosis Therapy
  • 相关文献

参考文献29

  • 1吴效科,常惠,张颖,杨新鸣,侯丽辉.多囊卵巢综合征流行病学调查进展[J].科技导报,2010,28(21):101-105. 被引量:80
  • 2Zawadzki JK,Dunaif A. Diagnostic criteria for polycystic ovary syndrome:towards a rational approach [M]//Dunaif A, Givens J, Haseltine F,et al. Polycystic ovary syndrome. Boston:Blackwell Scientific, 1992: 377.
  • 3Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod, 2004,19( 1 ) :41-47.
  • 4Ning N, Balen A, Brezina PR, et al. How to recognize PCOS : results of a web-based survey at IVF-worldwide. corn [J]. Reprod Biomed Online, 2013,26(5 ) : 500-505.
  • 5Azziz R,Carmina E,Dewailly D,et al. Androgen Excess Society. Positions statement:criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome:an Androgen Excess Society guideline [J]. J Clin Endocrinol Metab,2006,91 ( 11 ) :4237-4245.
  • 6Japanese Society of Obstetrics and Gynecology (JSOG). Constitute of Reproductive endocrinology. Reports of a new diagnostic criteria of PCOS in Japan [J]. Acta Obstet Gynecol Jpn,2007,59:868- 886.
  • 7中华人民共和国国家卫生和计划生育委员会.多囊卵巢综合征诊断[EB/OL].[2011-07-07].http://.moh.v.cn/zwgkzt/s9494/201107/89~f58dd55945618ccOae5aa07t3f47.shtml.
  • 8Legro RS,Arslanian SA,Ehrmann DA,et al. Diagnosis and treatment of polycystic ovary syndrome:an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab,2013,98 (12) :4565-4592.
  • 9Lujan ME, Jarrett BY, Brooks ED, et al. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume [J]. Hum Reprod, 2013,28 (5) : 1361-1368.
  • 10K6ninger A, Koch L, Edimiris P, et al. Anti-Mullerian Hormone : an indicator for the severity of polycystic ovarian syndrome [J]. Arch Gynecol Obstet, 2014,290 ( 5 ) : 1023-1030.

二级参考文献55

  • 1陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 2李蓉,乔杰,陈咏键,刘平,陈贵安,李美芝.多囊卵巢综合征对体外受精胚胎移植结局的影响[J].中国生育健康杂志,2006,17(2):92-95. 被引量:7
  • 3杨冬梓,冯淑英,李琳,陈晓莉,赵晓苗,陈亚肖.青春期多囊卵巢综合征[J].现代妇产科进展,2006,15(10):721-734. 被引量:23
  • 4喻银,肖红梅,卢光琇.汉族妇女多囊卵巢综合征胰岛素抵抗及相关代谢特征分析[J].中国现代医学杂志,2007,17(13):1625-1627. 被引量:10
  • 5Costello MF, Eden JA. A systemic review of the reproductive system effects of metformin in patients with polycystie ovary syndrome. Fertil Steril, 2003, 79(1): 1-13.
  • 6Trounson A,Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes re- covered from untreated polycystic ovarian patients. Fertil Steril, 1994, 62(2):353-62.
  • 7Rotterdam ESHRE/ASRM-sponsored PCOS ConcensusWorkshop Group. Revised 2003 comcensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 2004, 81(1): 19-22.
  • 8Lin YH, Hwang JH, Huang LW, et al. Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes. Hum Reprod, 2003, 18(8): 1632-6.
  • 9Soderstrom-Anttila V, Makinen S, Tuuri T, et al. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod, 2005, 20 (6): 1534-40.
  • 10Mikkelsen AL, Lindenberg S. Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction, 2001, 122(4):587-92.

共引文献94

同被引文献638

引证文献71

二级引证文献530

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部